Following Priority Review, the U.S. FDA granted HYRNUO® (sevabertinib) approval for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) ...

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer The first patient has been dosed in the ...

Abstract: Various static code analysis tools have been designed to automatically detect software faults and security vulnerabilities. This paper aims to 1) conduct an empirical evaluation to assess ...

At the beginning of each NFL season, it can be difficult to imagine widespread challenges to the incumbent contending class. But when it comes to the postseason field, change is a given. Last season ...

Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...

Welcome back to Day 52 of the journey! In this video, we dive deep into the essential world of persistent storage in Kubernetes, focusing specifically on storage classes. Understanding how to manage ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Instance main methods and unnamed classes, coming in Java 21, will forever change how developers ...

ABSTRACT: Security vulnerabilities are a widespread and costly aspect of software engineering. Although tools exist to detect these vulnerabilities, non-machine learning techniques are often rigid and ...

Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE Mark ...

Healthier lifestyles were associated with improved overall survival but not prostate cancer–specific survival in a multiethnic cohort of patients with nonmetastatic prostate cancer. Behavioral scores ...